Tenon Medical, Inc. TNONW
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
-29.53
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.9M | -$12.6M | $2.4M | -$11.0M | $5.0M |
| 2024 | $3.3M | -$13.7M | $1.7M | -$10.1M | $6.0M |
| 2023 | $2.9M | -$15.6M | $1.2M | -$12.5M | $778,000 |
| 2022 | $691,000 | -$18.9M | -$641,000 | -$12.9M | $6.3M |
| 2021 | $160,000 | -$7.0M | $105,000 | -$4.4M | -$20.6M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Geist Wyatt D. | Chief Innovation Officer | 2026-05-01 | Grant | 136,401 | — |
| Grawey Nathaniel A. | Chief Commercial Officer | 2026-05-01 | Grant | 68,201 | — |
| Williamson Kevin | Chief Financial Officer | 2026-03-03 | Option exercise | 1,041 | — |
| Williamson Kevin | Chief Financial Officer | 2026-01-05 | Tax withheld | 18,518 | $0.93 |
| Hochschuler Stephen | director | 2026-01-05 | Tax withheld | 3,327 | $0.93 |
| WEIGLE ROBERT K | director | 2026-01-05 | Tax withheld | 3,413 | $0.93 |
| GINN RICHARD | Chief Technology Officer | 2026-01-05 | Tax withheld | 47,426 | $0.93 |
| Williamson Kevin | Chief Financial Officer | 2026-01-01 | Option exercise | 58,987 | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -29.53 (distress)
- Working capital / assets 0.33
- Retained earnings / assets -7.556
- EBIT / assets -1.189
- Equity / liabilities 0.881
Source: SEC EDGAR filings · CIK 0001560293 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.